<![CDATA[Genmab — Januar 2018]]>

]]>https://dev.proinvestor.com/forum/topic/451514/genmab-januar-2018RSS for NodeSun, 14 Jun 2026 02:46:07 GMTMon, 01 Jan 2018 14:25:23 GMT60<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:59:42 GMT]]>Dr Ronald Levy, Professor of Medicine at Stanford University er manden bag projektet

]]>https://dev.proinvestor.com/forum/post/10171549https://dev.proinvestor.com/forum/post/10171549Wed, 31 Jan 2018 21:59:42 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:58:37 GMT]]>Imponerende, måske et gennembryd der batter

]]>https://dev.proinvestor.com/forum/post/10171550https://dev.proinvestor.com/forum/post/10171550Wed, 31 Jan 2018 21:58:37 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:57:56 GMT]]>The combination of a TLR agonist and an activating antibody against OX40 amplifies these antitumor T cells and induces their action throughout the body against tumor at nontreated sites.

]]>https://dev.proinvestor.com/forum/post/10171547https://dev.proinvestor.com/forum/post/10171547Wed, 31 Jan 2018 21:57:56 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:54:34 GMT]]>Here you go Solsen http://stm.sciencemag.org/content/10/426/eaan4488.full

]]>https://dev.proinvestor.com/forum/post/10171548https://dev.proinvestor.com/forum/post/10171548Wed, 31 Jan 2018 21:54:34 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:42:12 GMT]]>To spændende nyheder Solsen, nu er det sgu svært at lukke øjnene selv med nathuen godt trukket ned om ørerne. 12% er meget hvis det er sandt og bekræfter min teori fra i går, men må være en and, ellers er finanstilsynet ekstremt sløve, men er jo også en offentlig instans.

]]>https://dev.proinvestor.com/forum/post/10171545https://dev.proinvestor.com/forum/post/10171545Wed, 31 Jan 2018 21:42:12 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:38:47 GMT]]>I Texas kørte de med 5 forskellige ICI'er, den ene Dara

]]>https://dev.proinvestor.com/forum/post/10171544https://dev.proinvestor.com/forum/post/10171544Wed, 31 Jan 2018 21:38:47 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:36:29 GMT]]>Sygt så mange forsøg der er igen med dara var ikke klar over hvor omfattende det er :=)

]]>https://dev.proinvestor.com/forum/post/10171542https://dev.proinvestor.com/forum/post/10171542Wed, 31 Jan 2018 21:36:29 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:32:14 GMT]]>Hvad tror du det er?

]]>https://dev.proinvestor.com/forum/post/10171540https://dev.proinvestor.com/forum/post/10171540Wed, 31 Jan 2018 21:32:14 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 21:24:55 GMT]]>http://www.telegraph.co.uk/science/2018/01/31/cancer-jab-eliminates-tumours-body-even-spread-start-human-trials/ Hvem finder først hvilke to drugs der er tale om ?

]]>https://dev.proinvestor.com/forum/post/10171551https://dev.proinvestor.com/forum/post/10171551Wed, 31 Jan 2018 21:24:55 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 20:21:27 GMT]]>Nej har kun et skærmprint.

]]>https://dev.proinvestor.com/forum/post/10171539https://dev.proinvestor.com/forum/post/10171539Wed, 31 Jan 2018 20:21:27 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 19:56:23 GMT]]>Solsen har du link til Bloomberg? Jeg synes ikke jeg kunne finde noget

]]>https://dev.proinvestor.com/forum/post/10171538https://dev.proinvestor.com/forum/post/10171538Wed, 31 Jan 2018 19:56:23 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 18:57:46 GMT]]>Det tror jeg de fleste vil.

]]>https://dev.proinvestor.com/forum/post/10171541https://dev.proinvestor.com/forum/post/10171541Wed, 31 Jan 2018 18:57:46 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 18:55:56 GMT]]>Lidt underligt viser Bloomberg, at Artisan har 12% af Genmab aktierne ?

]]>https://dev.proinvestor.com/forum/post/10171543https://dev.proinvestor.com/forum/post/10171543Wed, 31 Jan 2018 18:55:56 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 18:54:38 GMT]]>Jeg kunne mistænke, at du gerne ville sælge for den præmie 🙂

]]>https://dev.proinvestor.com/forum/post/10171546https://dev.proinvestor.com/forum/post/10171546Wed, 31 Jan 2018 18:54:38 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 18:53:25 GMT]]>120 % præmie til Ablynx

]]>https://dev.proinvestor.com/forum/post/10171537https://dev.proinvestor.com/forum/post/10171537Wed, 31 Jan 2018 18:53:25 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 18:49:56 GMT]]>Nice one Solsen. 🙂

]]>https://dev.proinvestor.com/forum/post/10171534https://dev.proinvestor.com/forum/post/10171534Wed, 31 Jan 2018 18:49:56 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 18:48:59 GMT]]>Tak doc4. Men stage I er vel ikke " recurrent or metastatic colorectal cancer", som der er tale om i dara-Opdivo-studiet? https://www.clinicaltrials.gov/ct2/show/NCT02060188?term=daratumumab+bms&rank=2

]]>https://dev.proinvestor.com/forum/post/10171536https://dev.proinvestor.com/forum/post/10171536Wed, 31 Jan 2018 18:48:59 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 18:28:35 GMT]]>https://www.cnbc.com/video/2018/01/29/big-pharma-paying-top-dollar-for-biotech-assets-pro.html

]]>https://dev.proinvestor.com/forum/post/10171533https://dev.proinvestor.com/forum/post/10171533Wed, 31 Jan 2018 18:28:35 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 17:48:25 GMT]]>https://link.springer.com/article/10.1134/S002689331205010X

]]>https://dev.proinvestor.com/forum/post/10171532https://dev.proinvestor.com/forum/post/10171532Wed, 31 Jan 2018 17:48:25 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 17:47:41 GMT]]>@Bulder 16:15..."CD38 expression was observed in all cases of stage-I colorectal cancer; at stages II, III, and IV, it was significantly less frequent."

]]>https://dev.proinvestor.com/forum/post/10171531https://dev.proinvestor.com/forum/post/10171531Wed, 31 Jan 2018 17:47:41 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 15:51:53 GMT]]>En ny præsentation fra Genmab opsummerer Dara studier ganske fint på de sidste sider: http://files.shareholder.com/downloads/AMDA-KPIBN/5907694987x0x969818/46F507CB-688F-4EBD-9FF6-B7D1C07A7C3E/IR_January_Presentation_29_Jan_18.pdf

]]>https://dev.proinvestor.com/forum/post/10171530https://dev.proinvestor.com/forum/post/10171530Wed, 31 Jan 2018 15:51:53 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 15:11:20 GMT]]>Ret beset har vi jo heller ikke hørt et ord fra Callisto. Den eneste grund til opmærksomheden her på PI er jo Limo Chens pointer i lungecancer, som er offentliggjorte. Selve studiet henligger jo i totalt mørke.

]]>https://dev.proinvestor.com/forum/post/10171527https://dev.proinvestor.com/forum/post/10171527Wed, 31 Jan 2018 15:11:20 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 15:03:52 GMT]]>OK takker

]]>https://dev.proinvestor.com/forum/post/10171526https://dev.proinvestor.com/forum/post/10171526Wed, 31 Jan 2018 15:03:52 GMT<![CDATA[Reply to Genmab — Januar 2018 on Wed, 31 Jan 2018 14:42:30 GMT]]>Det er mig der roder: Tyktarmsstudiet er checkmate 142 med flere andre stoffer end dara. Det rene (nye) dara+opdivo studie er det næstlængst til højre på den planche du henviser til. Så jeg tror ikke BMS ser noget særligt i colon.

]]>https://dev.proinvestor.com/forum/post/10171528https://dev.proinvestor.com/forum/post/10171528Wed, 31 Jan 2018 14:42:30 GMT